PainChek secures major US deal with Sabra REIT
PainChek (ASX:PCK) announced a master services agreement with Sabra Health Care REIT (NASDAQ:SBRA).
Todas as matérias desta categoria, das mais recentes às mais antigas.
PainChek (ASX:PCK) announced a master services agreement with Sabra Health Care REIT (NASDAQ:SBRA).
Noxopharm (ASX:NOX) has announced the resignation of its CEO and Managing Director, Dr Gisela Mautner.
Entropy Neurodynamics (ASX:ENP) announced a pivotal breakthrough in its TRP-8803 clinical programme.
Clarity Pharmaceuticals (ASX:CU6) has announced a landmark commercial manufacturing agreement with Nucleus RadioPharma.
Monash IVF Group (ASX:MVF) has entered a critical period of negotiation following a revised, non-binding indicative proposal from a high-profile consortium.
Talius Group (ASX:TAL) has secured a master services agreement with Seventh-Day Adventist Aged Care (South Queensland).
Pro Medicus (ASX:PME) announced a five-year contract renewal with Chicago-based Northwestern Medicine.
Telix Pharmaceuticals (ASX:TLX) and Regeneron Pharmaceuticals (NASDAQ:REGN) have announced a global collaboration.
The US FDA has accepted Telix Pharmaceuticals' (ASX:TLX) NDA for brain cancer imaging agent Pixclara.
AVITA Medical (ASX:AVH) has finalised a ten-year agreement with the Biomedical Advanced Research and Development Authority valued at up to $25.5 million.
FDA clears Mesoblast (ASX:MSB) will begin a registrational trial for Ryoncil in treating Duchenne muscular dystrophy.
Imricor Medical Systems (ASX:IMR) submitted its NorthStar 3D Mapping System for FDA clearance.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade